Role of defibrillation threshold testing during implantable cardioverter-defibrillator placement: data from the Israeli ICD Registry.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yoav,Arnson

第一单位： Department of Cardiology, Meir Medical Center, Kfar Saba, Israel. Electronic address: yoav.arnson@gmail.com.

作者： Yoav,Arnson ^[1] ; Mahmoud,Suleiman ^[2] ; Michael,Glikson ^[3] ; Ron,Sela ^[4] ; Michael,Geist ^[5] ; Guy,Amit ^[6] ; Jorge E,Schliamser ^[7] ; Ilan,Goldenberg ^[3] ; Shlomit,Ben-Zvi ^[3] ; Katia,Orvin ^[8] ; Shimon,Rosenheck ^[9] ; Nahum,Adam Freedberg ^[10] ; Boris,Strasberg ^[8] ; Moti,Haim ^[11]

作者单位： Department of Cardiology, Meir Medical Center, Kfar Saba, Israel. Electronic address: yoav.arnson@gmail.com. ^[1] Rambam Medical Center, Haifa, Israel. ^[2] Department of Cardiology, Tel Hashomer Medical Center, Tel Aviv, Israel. ^[3] Naharia Medical Center, Naharia, Israel. ^[4] Department of Cardiology, Wolfson Medical Center, Holon, Israel. ^[5] Department of Cardiology, Soroka Medical Center, Beer Sheva, Israel. ^[6] Heart Institute, Carmel Medical Center, Haifa, Israel. ^[7] Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel. ^[8] Arrhythmia Therapy Center, Heart Institute, Hadassah Hebrew University Medical Center, Jerusalem, Israel. ^[9] Department of Cardiology, Ha׳Emek Medical Center, Afula, Israel. ^[10] Department of Cardiology, Meir Medical Center, Kfar Saba, Israel. ^[11]

关键词 Complications Defibrillation threshold Defibrillation threshold testing Implantable cardioverter-defibrillator Mortality Outcomes